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Background: Work with experimental scrapie in sheep has been performed on-site for many years including
studies on PrPSc dissemination and histopathology of organs and tissues both at preclinical and clinical stages. In
this work serum was sampled at regular intervals from lambs which were infected immediately after birth and from
parallel healthy controls, and examined for acute phase proteins. In contrast to earlier experiments, which
extensively studied PrPSc dissemination and histopathology in peripheral tissues and brain, this experiment is
focusing on examination of serum for non-PrPSc markers that discriminates the two groups, and give insight into
other on-going processes detectable in serum samples.
Results: There was clear evidence of an acute phase response in sheep with clinical scrapie, both experimental and
natural. All the three proteins, ceruloplasmin, haptoglobin and serum amyloid A, were increased at the clinical stage
of scrapie.
Conclusion: There was evidence of a systemic measurable acute phase response at the clinical terminal end-stage
of classical scrapie.Background
Scrapie is a fatal neurodegenerative disease of sheep, and
is one of the diseases in the group called Transmissible
Spongiform Encephalopathies (TSEs), where PrPSc, an
abnormal form of the normal cellular PrPC, is believed
to be the infective agent [1]. Other TSEs are Creutzfeldt-
Jakob disease (CJD) in man, Bovine Spongiform Enceph-
alopathy (BSE) in cattle and Chronic Wasting Disease
(CWD) in deer, to mention a few. TSEs were at first
regarded as neurodegenerative diseases without an in-
flammatory component, but the characterisation of a
marked functional activation of microglial cells and
identification of increased cytokine expression in the
affected areas of the brain, points towards a localised in-
flammatory response [2]. The PrPSc and its dissemin-
ation and related histopathology have been, and is still,
extensively studied in several different animal models,
especially in murine models. Scrapie affected sheep
(both experimentally and naturally infected) with the* Correspondence: siv.meling@nvh.no
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reproduction in any medium, provided the ormost susceptible PrP genotype, VRQ/VRQ and VRQ/
ARQ, have a preclinical PrPSc dissemination in periph-
eral lymphoid tissue throughout the body, and this has
proven useful in preclinical diagnosis by immunohisto-
chemistry (IHC) and Western Blot (WB) of sheep of such
PrP genotypes [3-8]. Less susceptible PrP genotypes have
shown to have a less predictable lymphatic tissue involve-
ment, thus increasing the risk of false negative lymphoid
biopsies [9,10]. During the last decade there has been an
increasing interest in the search for other non-PrPSc dis-
ease related biomarkers for TSEs by the use of different -
omics techniques, especially in the search for preclinical
diagnostic markers that could be used for diagnostics in
the live animal. In the search for non-PrPSc markers of
scrapie much work has been done in screening mostly
brain, but also peripheral lymphoid tissue and serum in
different murine models, for different gene expressions,
especially different cytokines which have been detected
both at mRNA and protein levels [11-16]. Not all of
these murine models show the same results, and
Tribouillard-Tanvier et al (2009) suggest that this may
be attributable to the animal model used [15]. Recently,
Huzarewich et al (2010) published a review on different
potential disease markers detected in the application ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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for a non-PrPSc marker of prion diseases it is quite no-
ticeable that many of the significant genes and proteins
are linked to the activation of microglia in the brain,
and the processes in and around the innate immune
response including the acute phase response.
Measurements of serum or plasma proteins in relation
to diagnostics have been performed for many years, and
particularly acute phase proteins (APPs), which increase
or decrease in response to a number of inflammatory
insults as part of the acute phase response (APR) [18].
The APR is part of the innate immune system and first
line of defence. It is the organism’s first response to tis-
sue injuries, infections, stress and inflammation, and is
characterised by a local reaction at site of injury fol-
lowed by a number of systemic reactions including
changes in the concentration of acute phase proteins
(APPs) [19-21]. The majority of serum proteins are
synthesised in the liver, including the APPs, which are
part of the APR. The APR is thought to be beneficial to
the animal in restoring homeostasis, and the response is
tightly controlled by negative feedback loops, as the
APR itself can cause harm if it comes out of control.
Measurements of APPs in serum/plasma can be used
to assess the innate immune system’s systemic response
to infection, inflammation, trauma and other patho-
logical injuries; they have even been suggested as mar-
kers for overall herd/flock health in farm animals by
detecting subclinical conditions. The APPs are mainly
synthesised in hepatocytes, but also extrahepatically, and
they are induced by cytokines including interleukin-1
(IL-1), interleukin-6 (IL-6) and tumor-necrosis factor-
alpha (TNF-α) released mainly from macrophages,
monocytes and astrocytes at site of lesion [22,23]. Mea-
surements of APPs have shown to be useful as diagnos-
tic and prognostic markers in several conditions in
addition to assessing response to treatment, as their
levels correspond to tissue damage. APPs lack specificity,
but are highly sensitive indicators of inflammation and
tissue injury [24].
Serum amyloid A (SAA), haptoglobin (Hp) and Ceru-
loplasmin (Cp) have been described as important APPs
in sheep, with SAA and Hp being the major APPs in this
animal species [22,23,25]. Increased plasma and serum
levels of these proteins have been associated with a var-
iety of diseases and conditions, and neither SAA nor Hp
are usually detected at all in healthy sheep. Hp and Cp
have been shown to increase significantly in experimen-
tal Mannheimia haemolytica infection, and remain ele-
vated for ten days before returning to pre-infection
levels [26]. Cp is an effective antioxidant, also in the
CNS, protecting neural cells from oxidative stress, which
plays a crucial role during CNS injury, when free iron
and reactive oxygen species (ROS) increase [27].Moderate increases in SAA and Hp have been
detected in subclinical infections, and, on this basis, it
has been suggested that measurements of these two
APPs can become useful in determining health status in
flocks. As there is an association between APP levels
and the severity of disease it has also been proposed that
APPs can be used as prognostic indicators [25,26,28-33].
This work is part of a larger study to investigate non-
PrPSc markers in serum from experimentally infected
sheep. In previous work by Ersdal et al. the inoculation
was performed between 46 and 61 days of age, while this
later model, described by Ulvund et al, the lambs are
inoculated at birth [34,35]. This later model has a rela-
tively short incubation period where the animals show
clinical disease already at 4–5 months of age, and the
distribution of PrPSc is extensive in the brain at clinical
end stage. Initial proteomic analysis of serum from these
sheep at the terminal clinical end stage revealed serum
amyloid A (SAA) levels in the scrapie group to be sig-
nificantly differently expressed from the healthy group,
and by latent variable methods, was found to discrimin-
ate affected from healthy sheep with 95% correct classifi-
cation rate (data not shown). To our knowledge, this
represents the first verification of a measurable APR in
sheep with both experimental and naturally occurring
classical scrapie. The APR was mainly measured by Hp,
SAA and Cp levels in serum.
Results
Experimental classical scrapie model
This experimental model of classical scrapie has been
reported elsewhere [34,35]. All the animals in the scrapie
group developed clinical signs of classical scrapie within
time of euthanasia at 23 weeks of age/post infection.
Already at four months of age, very subtle clinical signs
of pruritus and wool eating were detected; though only
on video surveillance. Clear clinical signs of disease were
first obvious during the last week before euthanasia, and
clinical presentation deteriorated quickly with noticeable
pruritus, wool changes, ataxia, depressed mental status
and recumbency. Very few macroscopic changes were
recorded during post mortem examination, apart from
redness and abrasions of skin in areas of pruritus and
wool loss. The brain from all the animals in both groups
were examined for PrPSc by immunohistochemistry
(IHC) and WB, and only the animals in the scrapie group
were positive (data not shown).
Total protein and albumin measurements and globulin
calculation
The mean total protein (TP) concentration in both
groups increased steadily from six weeks of age (woa)
until a relatively high peak at 18 woa (control group,
mean ± SEM, 79.5 ± 0.87 mg/ml) and at 20 woa (scrapie
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group then decreased to reach 68.1 ± 1.71 mg/ml at 24
woa. TP level in the scrapie group also declined after
peaking, but later increased again at euthanasia at 23
woa (77.2 ± 3.53 mg/ml), creating a significant differ-
ence between the groups (p< 0.05). This significant dif-
ference in TP level was in majority due to the higher
globulin level in the scrapie group (49.9 ± 2.3 mg/ml)
compared to the control group (40.2 ±1.5 mg/ml).
Globulin levels in both groups increased and decreased
in the same fashion as TP levels, and the fluctuation in
TP levels seemed to be the result of globulin changes.
This was not the case at 14 woa, where there was a
significant difference in TP levels between the groups
(p< 0.05). Coinciding with this, there was a significant
decrease in albumin concentration (p< 0.05) in the
scrapie group (23.4 ± 0.8 mg/ml) compared to the con-
trol group (27.5 ± 0.9 mg/ml). Changes in these proteins
over time are presented in Figure 1.
Acute phase protein responses in experimental classical
scrapie
SAA and Hp concentrations were from undetectable to
very low in the majority of samples during the study.
Analytical sensitivity of the two kits used was 0.3 μg/ml
for SAA and 0.005 mg/ml for Hp (according to the
manufacturer). One control animal had detectable SAA
response at ages 10, 12 and 18 woa, and increased Hp
measurements at 10 and 14 woa. Two scrapie animals
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Figure 1 Serum levels of total protein, Albumin and calculated Globu
level in control group (♦ blue) and scrapie group (× purple), Globulin levels
albumin levels for control group (■ red) and scrapie group (∗ turquoise). E
each time of sampling.woa respectively. No clinical signs of disease were de-
tectable at any of these incidences in either group. From
20 woa, SAA and Hp levels increased in the scrapie
group, while remained undetectable in the control
group. Measurements in serum from one of the animals
in the scrapie group had only a moderate level of SAA
(2.69 μg/ml) at 22 weeks and undetectable level of end
stage, and Hp measurements at the same times where
at the levels measured for the control group.
The four animals in the control group were sampled
ten times each, and out of these 40 individual samples,
only three had detectable SAA levels, and all the three
samples were from the same animal (ranged 0 to
32.3 μg/ml). Of the 50 samples from the scrapie group,
39 had undetectable SAA levels, two animals had iso-
lated incidences of elevated SAA levels at a subclinical
stage of scrapie at 10 (1.54 μg/ml) and 14 (18.46 μg/ml)
woa. From 20 weeks of age, there was a tendency for
SAA levels to increase more dramatically until time of
euthanasia (ranged 0 to 222.8 μg/ml). The individual
SAA measurements are shown in dot plots representing
each time point sampled in Figure 2.
Hp levels in the control group were low throughout
the sampling period with a mean value of 0.11 ± 0.01 mg/
ml, and the mean level in the scrapie group up until
22 weeks of age was similar at 0.10 ± 0.02 mg/ml. There-
after the haptoglobin level increased steeply to reach a
mean value of 3.0 ±1.17 mg/ml. Hp measurements are
presented individually in a dot plot at each time point in
Figure 3.min and Globulin levels  .
s-tp s-alb s-glb
4 16 18 20 22 23
ge/Weeks
lin in both groups from 6 to 23/24 weeks of age. Total protein
for control group (▲ green) and scrapie group (● orange), and
ach time point is presented as the mean values for each group at
2,0 40 2,0 252,0
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Figure 2 Comparison of difference in SAA levels in serum between healthy controls and scrapie infected sheep from six to
23/24 weeks of age. Each of the individual five scrapie samples (red dots) and four control samples (blue dots) are presented individually as a
single dot to indicate the measured serum amyloid A (SAA) level which is presented on y-axis in μg/ml. At most time points, individual samples
in both groups were below the detection range of the SAA kit, and thus the dots appear on top of each other as one single dot at 0.0 μg/ml.
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throughout most of the studied period, but the most
prominent difference was detectable from 22 weeks of
age and onwards. During the last fortnight, the Cp levels
in the control group decreased, while there was a sharp
increase in the scrapie group, resulting in a significant
difference (p< 0.05) between the two groups at time of
euthanasia (31.7 ± 6.7 vs. 17.6 ± 2.0). Figure 4.
Natural cases of classical scrapie
All the natural cases of classical scrapie were confirmed
by histopathological examination of the brain by typical
lesions as well as detection of PrPSc [3,35]. Four out of
these five animals had shown pruritus for more than
three weeks, two of these developed severe neurological
signs before euthanasia, and one animal was without any
visible clinical signs (Table 1). TP levels in these five
sheep ranged from 57.6 to 93.8 mg/ml (70.9 ± 7.1 mg/
ml). Albumin levels were relatively stable for all five
sheep at 22.6 ± 0.8 mg/ml, and slightly lower in one sheep
(19.6 mg/ml). Calculated globulin levels ranged from34.5 to 70.1 mg/ml (48.2 ± 7.3 mg/ml). Hp concentration
was compared to the experimental control group and not
found to be statistically different (p> 0.05). One animal
had a very high level of Hp at 7.15 mg/ml, while the
remaining four had a mean of 0.18 mg/ml. All the ani-
mals had detectable SAA levels, ranged from 0.43 to
273.3 μg/ml, with significant difference from the control
group (p< 0.05). Results for all the measured serum pro-
teins are presented in Table 2.
Evaluation Hp and SAA kit performance
The coefficients of variation for both kits are presented
in Table 3. Intra-assay CV for Hp and SAA was 4.6%
and 10.6%, respectively, and inter-assay CV for Hp and
SAA was 0.9% and 9.1%. The limitations in these mea-
surements were that the inter-assay CV was based on
only two separate plates and the first plate mean was
calculated from only one duplicate. The second mean
was calculated from the same duplicate samples as used
for intra-assay CV. To achieve a better estimate of the
inter-assay CV, more samples and assays would be
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Figure 3 Comparison of difference in Hp levels in serum between healthy controls and scrapie infected sheep from six to 23/24 weeks
of age. Scrapie (red dots), controls (blue dots), haptoglobin (Hp) levels measured in mg/ml indicated on y-axis and groups are presented on
the x-axis. Each sample is individually plotted (four control samples and five scrapie samples), but, at some time points, the dots appear as one
single measurement due to very similar values and the scale accommodates the scrapie measurements, as they show more variation and a
higher levels.
Figure 4 Comparison of ceruloplasmin (Cp) between healthy
controls and scrapie infected sheep from six to 23/24 weeks
of age. Scrapie (♦ red dotted line), controls (■ blue),
Ceruloplasmin (Cp).
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bers of samples as presented by the manufacturer.
Discussion
In this work, we describe increased levels of certain
APPs in sheep with experimental and natural cases of
clinical classical scrapie. Such rise of these APPs in
sheep has not earlier been published in classical scrapie.
Regarding protein degradation during storage, serum
samples from experimental scrapie had been stored in
aliquots at −70 °C, and the sera from natural cases had
been stored at −20 °C. All the samples had been stored
for more than one year, and one of the natural cases was
from 1994. The deteriorating effects on protein concen-
tration in these samples are unknown, but it has been
shown that albumin and total proteins levels remain
stable for at least eight months in canine serum at −20 °C
[36] and recently Gislefoss et al. reported non-significant
differences of albumin in samples stored for 25 years,
two years and one month [37]. Based on these examina-
tions, the results achieved in this work were regarded to
Table 1 Presentation of the natural cases of classical scrapie
ID Admitted Sampled Age Genotype Clinical presentation Brain Brain PrPSc
S1 10.02.94 14.02.94 6 VRQ/VRQ Pruritic, nervous, tremors Vacuolisation with astrocytosis Positive
S2 20.03.96 07.05.96 5 VRQ/VRQ Pruritic, ataxia, nervous, altered mental state Vacuolisation with astrocytosis Positive
S3 27.08.98 16.09.98 7 ARQ/VRQ Pruritus with hyperkeratosis Vacuolisation with astrocytosis Positive
S4 14.07.99 15.09.99 2 ARQ/VRQ Normal Vacuolisation with astrocytosis Positive
S5 14.02.01 23.02.01 7 VRQ/VRQ Pruritic Vacuolisation with astrocytosis Positive
Overview over admission dates and time of euthanasia, age in years, PrP genotype, clinical presentation at time of euthanasia and pathognomonic
histopathology of the brain of the five natural classical scrapie cases. PrPSc was identified by immunohistochemistry on sections of the brain as described by
Ersdal et al. (2005) [3]
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samples. Cp measurements were based on its oxidative
activity, which decreases over time in storage, and there-
fore Cp was not measured in the naturally occurring
classical scrapie cases.
As age has a major effect on the concentration of
many serum proteins, it was difficult to find reference
ranges based on animals in the age range of 6 weeks to
six months of age [17,38-41]. Total serum protein has a
wide dynamic range, thereby making analysis difficult to
interpret when comparing to reference ranges devel-
oped by others. In addition, the protein levels may also
be influenced by breed, management systems and analyt-
ical methods, and available reference ranges usually do
not give either of these influential factors. Therefore, it
may be misleading to uncritically compare results with
any reference range listed. The animals used in this pro-
ject were kept under very strict management system,
and all the animals were managed similarly, they are of
the same breed and age. Due to reasons mentioned
above, the serum proteins were compared between the
groups in question at same age, breed and feeding re-
gime and management.
The total protein and albumin profile changed over
time in a similar fashion to what was described by
Kaneko [42], although the total protein levels in both
groups were slightly to moderately higher than those
reported for lambs younger than 12 months. AlbuminTable 2 TP, Alb, Glb, Hp and SAA measurements in the











S1 64.2 23.7 40.5 0.29 273.30
S2 80.5 19.6 60.9 7.15 1.31
S3 93.8 23.7 70.1 0.18 8.55
S4 58.2 23.7 34.5 0.16 0.43
S5 57.6 22.5 35.1 0.07 0.43
C 0.06 -
Level of different proteins in serum from five cases of naturally occurring
classical scrapie. Hp and SAA levels were compared to measurements of the
oldest animals in the control group. The “-“ indicates that measured levels
were below detection range of test.levels were clearly lower. As albumin and globulins
make up most of the total serum protein, globulin levels
were higher than indicated by others [38-41]. There was
a general increase in total protein from birth, combined
with a minimal change in albumin and a marked in-
crease in globulins with advancing age, reaching high
levels at 18 – 20 weeks of age. At birth, the total protein
is relatively low, but increase rapidly after ingestion of
colostrum and maternal immunoglobulins. As globulins
declined due to normal turnover, the animals begin to
synthesize their own immunoglobulins, and reach adult
levels of albumins and globulins in young adulthood.
Total protein levels reached above average adult levels
as a result of a minor decrease in albumin and progres-
sive increase in globulins [42]. From 20 weeks of age,
there were significant differences in TP levels between
the groups, with a marked increase in the scrapie group.
This increase was mainly due to a significant increase in
the globulin fraction. As the APPs and immunoglobulins
are part of the globulin fraction, this increase could be
the result of increased synthesis of APPs, as seen for the
three positive APPs tested in this work: Hp, SAA and
Cp. Several studies have failed to describe a significant
increase in immunoglobulins at clinical classical scrapie,
especially scrapie-specific IgG [43-45].
There are very few available reference ranges for APPs
in sheep, but recently Lepherd et al. [39] published good
reference ranges for SAA and Hp in young sheep. Al-
though these reference intervals were from a different
breed and sheep kept under different management sys-
tems, they were in the same age range and seemed ap-
propriate in that manner. Skinner and Roberts [32]
evaluated Hp levels in a variety of conditions, both infec-
tious and non-infectious, in addition to healthy sheep,
and concluded that Hp values above 0.2 g/l were “posi-
tive”. It is also interesting to see that 7% of the randomly
selected healthy sheep had a positive Hp value, which
could indicate the presence of subclinical conditions. In
other studies, levels of SAA below 2 μg/ml (range 0 to
29.4) have been reported in clinical healthy sheep
[33,39]. APPs are often reported as undetectable to very
low levels in healthy individuals, and subclinical condi-
tions would often lead to a temporary elevation before
Table 3 Intra- and inter-assay coefficient of variation of Hp and SAA kits
Intra-assay CV Inter-assay CV
n Average % CV Mean of means SD of means % CV of means
Hp 7 4.6 11.62 0.10 0.9
SAA 13 10.6 22.28 2.04 9.2
CV: Coefficient of variation; n: number of duplicate samples; SD: Standard Deviation; Hp: haptoglobin; SAA: Serum amyloid A.
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in SAA and Hp seen approximately half-way through
the incubation period in two animals in the scrapie
group, and one control, could be due to a subclinical
condition. As no clinical signs of disease were detected
in any of the animals at this time, it is difficult to rule in
or out any specific conditions, including scrapie. There
is a possibility that the increase in SAA and Hp in the
two scrapie infected animals at 10 and 14 weeks of age
could relate to the expected PrPSc dissemination through
peripheral lymphoid tissue that is seen about half-way
through the incubation period in this experimental
model. This would need further testing to confirm.
Batxelli-Molina et al. (2010) reported transthyretin to
discriminate scrapie affected sheep from healthy sheep,
both during early asymptomatic phase and later during
the symptomatic phase, although only significant at the
late stage [46]. Transthyretin is a negative APP, and thus
decreased levels would be an expected finding along
with increased levels of positive APPs during an APR.
The clear and significant increase in SAA, Hp and Cp
measured at the clinical end stage indicate a detectable
APR at this stage of classical scrapie, both in the experi-
mental and the natural cases. This coincides well with
the pathological changes seen on histopathological
examination of the brain and the onset of severe clinical
disease seen at this late stage in this experimental model.
APPs levels are reported to be directly related to severity
of both tissue damage and level of inflammation, i.e.
they are specific markers for tissue damage and inflam-
mation [25]. Pro-inflammatory cytokines, like interleukin
6 (IL-6), interleukin-1 (IL-1) and tumor-necrosis factor
α (TNF-α), are released by damaged tissues locally and
into the circulation, where more inflammatory cells are
activated. These responses result in production of more
cytokines and inflammatory mediators circulating in the
blood acting on different target organs/cells leading up
to a systemic reaction with alteration in synthesis of
APPs in the liver and activation of the hypothalamic-
pituitary-adrenal (HPA) axis [30]. This stimulation will
lead to increased production of cortisol by the adrenal
glands, which has a negative feedback effect on this
axis. This stimulation of the HPA axis could contribute
to the hypercorticism with increased cortisol, 20β-
dihydrocortisol and cortisone detected in plasma and
urine of sheep with subclinical and clinical scrapie thathas been reported with a certain discriminating level
[47-49]. Cytokines induce production of adrenocortico-
trophic hormone (ACTH) which in turn stimulates
synthesis of the corticosteroid, cortisol [50,51]. This is
an important regulatory feature in inflammatory and
cytokine responses, as adrenalectomized rodents show
increased mortality in experiments involving injection
of bacterial lipopolysaccharide, IL-1 or TNF-α. After
administration of glucocorticoids, these mice survived.
Thus by regulating cytokine production and action,
HPA axis contributes to modulation of the inflamma-
tory response [52].
SAA and Hp are characterised as major acute phase
proteins (APPs) in sheep and these are known to in-
crease with severity of tissue damage and level of inflam-
mation. Interestingly, the SAA response in these
experimental cases of scrapie are higher than levels
reported for mulesing and caseous lymphadenitis (CLA)
[29,31], and more in the region of experimental mastitis
[33]. It is tempting to think that the APP levels in the
naturally affected animals were related to extent of
histopathological changes in the brain, as the two ani-
mals with clear neurological signs had highest levels of
APP. The others with much lower levels of APP pre-
sented with pruritus as the main clinical sign, although
all of them had pathological changes in the brain. It is
also worth noticing the clear increase in the globulin
fraction of the TP in three out of the five natural cases
which was outside the reference range [42]. Relating
these results to clinical findings, these three sheep were
presented with the most severe clinical signs. Albumin
level in the worst clinically affected sheep were even
lower than the others, perhaps due to the on-going APR.
This leads to the thought that the systemic effects of
scrapie was related to severity of clinical signs and could
be measured in serum by SAA, Hp and Cp levels. Meas-
uring APP levels in serum may provide objective infor-
mation about the extent of the on-going process,
magnitude and duration may reflect the severity [22].
Even though the APR is a non-specific response, it is a
feature of clinical scrapie, and due to the high sensitivity
of the APR, measurements of APPs could be useful in
evaluation of the underlying pathological processes and
the systemic involvement of scrapie.
APPs respond rapidly to insults and the majority peak
about one day after the initial insult before returning to
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APPs have half-life of only 24 to 48 hours [25]. This
means that some important time points may have been
missed. Even though this experimental model gives fairly
predictive and consistent development of classical scra-
pie and clinical signs at around the same time, individual
differences may result in individual APP expression pro-
files. A different sampling strategy with more frequent
blood sampling could detect more subtle changes in the
APP profile of scrapie affected sheep throughout the in-
cubation period.
The exact underlying cause or the actual triggering
factors behind the detectable increase in APPs seen in
this study remains unknown, but this response coincides
well with the known accumulation of PrPSc in the brain,
astrocytosis and vacuolar changes seen at this late clin-
ical stage in VRQ/VRQ animals [3,4,34]. Several murine
models of classical scrapie show that pro-inflammatory
cytokines like IL-1, IL-6 and TNF-α, have increased ex-
pression at both mRNA and protein levels in brain, per-
ipheral lymphoid tissue and serum at the terminal end
stage [11,12,14,15]. Microglia produce pro-inflammatory
cytokines like IL-1, IL-6 and TNF-α upon activation,
and these are stimulators of the production of most
APPs [19,22,53]. Newsom et al. (2011) reported recently
quite an extensive list of proteins with altered expression
in brain, lymphoid tissue and serum both pre-clinically
and clinically in a murine model [14]. Volkel et al.
(2001) investigated plasma samples from patients with
CJD and found significant increase in both C-Reactive
Protein (CRP) and Interleukin-6 (IL-6) compared to
healthy controls, and concluded that these could be
assessed for cell damage and inflammation in similar
fashion to other markers[54]. Coe et al. (2001) showed
in an experimental scrapie murine model increasing
plasma levels of serum amyloid P with the onset and
progression of clinical signs [55]. There exist differences
in expression patterns both in the brain and peripheral
in the different murine models, and as postulated by
Newsom et al, this could be attributable to the animal
model used [14]. There are only a couple of records of
APPs being of significance in scrapie in sheep, serum
transthyretin and urinary α-1Antichymotrypsin have
been found to discriminate healthy from scrapie infected
both at pre-clinical and clinical stage of scrapie [46,56].
Conclusion
Based on the results from these different murine models
and the two reports on sheep, our results are of great
relevance as we described increased levels of the major
APPs in sheep which to our knowledge has not been
published in relation to scrapie in sheep. It is also inter-
esting to see that in an experimental model as the one
used here, where PrPSc dissemination, pathologicalchanges and onset of clinical disease are expected to
show little between individual differences, there is a
great variation in quantitative expression of the APPs.
Due to the low number of animals in this study and
the lack of disease specificity of the acute phase re-
sponse, these findings will need to be further evaluated
in larger groups to establish the expected dynamic range
of APPs in classical scrapie and other neurological and
non-neurological diseases of sheep. Comparable condi-
tions of interest are listeriosis, cerebrocortical necrosis,
focal symmetrical encephalomalacia and tick born fever
and encephalitis.
Methods
Experimental classical scrapie model
Nine Norwegian Rygja lambs with the same PrP geno-
type (homozygous V136R154Q171) were inoculated
through a stomach tube with 1 gram of pooled brain
material immediately after birth and before ingestion of
colostrum as described by Ulvund et al [34]. Four lambs
in the control group were inoculated with brain material
originating from healthy scrapie-free sheep of the same
genotype and PrPSc negative, and five lambs were inocu-
lated with brain material originating from confirmed
cases of classical scrapie. The lambs in both groups were
kept with their dams for the whole time length of the
project until euthanasia at 23–25 weeks of age. As the
control group was born about two weeks before the ani-
mals in the scrapie group, animals in the control group
were 25 weeks old at euthanasia, while the scrapie group
were only 23 weeks old. Each dam and offspring were
kept isolated in confined units without any contact with
other animals, and the scrapie group was under video
surveillance. Both groups were kept under similar condi-
tions and feeding regimes. Animal experiments were
approved by the Norwegian Animal Research Authority.
Blood sample collection
Non-fasting blood samples were collected into 10 ml
plain tubes (Terumo VenojectW) every fortnight from
six woa until euthanasia at 23/25 weeks of age, for a
total of ten times. Blood samples were allowed to clot at
room temperature for a minimum of 30 minutes and
maximum 60 minutes before processing. Serum was
pipetted in aliquots and frozen at −80 °C within two
hours of sampling. All the samples were subjected to
the same handling procedures throughout the experi-
ment. Serum was used for biochemistry, Hp and SAA
concentration analysis.
Natural cases of classical scrapie
During the early 1990s and until 2005, several cases of
suspected classical scrapie from farms in the surround-
ing area were received at the Norwegian School of
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search, for diagnostic purposes. The cases were admitted
for clinical examination, blood sampling, genotyping and
diagnosis. Sometimes these sheep were kept under video
surveillance for some time while in isolation, before eu-
thanasia and histopathological examination of the brain.
Blood sampling was performed at least 48 hours after
transport. Serum samples from five of these cases, stored
at - 20 °C, were used for protein analysis. Table 1.Protein measurement
Serum total protein was measured with ABX Pentra
Total Protein (TP), ceruloplasmin (CP) and albumin
(Alb) with ABX Pentra Albumin CP, both kits from
Horiba ABX Diagnostics (Montpellier, France). The oxi-
dase activity of Cp in serum was determined using a
colorimetric enzyme assay where oxidation of p-
phenylenediamine dihydrochloride was measured and
thereby estimating the Cp concentration in mg/dl. All
three measurements were adapted for COBAS MIRA
Plus equipment (Roche Diagnostics, Basel, Switzerland)
and routinely performed in the laboratory.
Globulin concentration was calculated by subtracting
albumin concentration from total protein measurement.
Serum Hp concentrations were determined manually
using the Phase™ Haptoglobin Assay kit (Tridelta Devel-
opment Limited, County Kildare, Ireland). All the sam-
ples were run in duplicates, and the mean of each
duplicate was used to determine final concentration.
The analyses were run according to manufacturer’s
instructions and immediately read at 600 nm on a Mul-
tiskan* GO Microplate Spectrophotometer using SkanIt
Software 3.2, both from Thermo Fisher Scientific (Wal-
tham, MA, USA). Samples with signal greater than the
highest standard were diluted and re-run until all the
signals fell within the linear part of the standard curve.
SAA concentrations were determined using Phase™
Range Multispecies SAA ELISA kit (Tridelta Develop-
ment Limited, County Kildare, Ireland). Sera were ini-
tially diluted 1:100 in Diluent buffer, and samples with
signals greater than the highest standard were further
diluted and re-run until all the signals fell within the lin-
ear part of the standard curve. Some samples were
diluted 1:1000. The only automated part of the proced-
ure was the washing steps, using the ELx50 Microplate
Strip Washer (BioTek Instruments, Inc., Winooski, VT,
USA). The absorbance was read on the Multiskan* GO
Microplate Spectrophotometer using SkanIt Software 3.2
at 450 nm using 630 nm as a reference.Statistical analysis
The results were adjusted for age such that the groups
were compared at the same animal age. At end pointcomparison, the lambs of the scrapie group were
23 weeks old and the control group was 24 weeks of age.
Significant difference (p< 0.05) of protein measure-
ments between the two groups at each sampling was
determined by calculation of the 95% confidence interval
for the difference in population medians. A non-
parametric test, Wilcoxon signed-rank test, was used for
calculation of confidence interval and p-values, as nor-
mal distribution of data could not be assumed due to
small sample size. SigmaPlot Version 12.0 (Systat Soft-
ware Inc., Erkrath, Germany) and Microsoft Excel 2010
were used.
Reference range used and evaluation of assay
performance
As no reference ranges for any of the proteins evaluated
here were available for Norwegian sheep breeds, and es-
pecially not for lambs in the age range of six to 24 weeks,
the level of proteins in the scrapie group was evaluated
in reference to the control group. The protein levels (TP,
Alb and Glb) in the natural cases were evaluated in rela-
tion to reference ranges provided by Kaneko [42], this
due to the great age difference to the experimental con-
trol group. HP and SAA levels were compared to the ex-
perimental control group at 24 woa.
Assay performance was evaluated by intra- and inter-
assay coefficients of variation (CV). These were calcu-
lated by dividing the standard deviation by the mean of
the same set of measurements and thereafter converting
it into percentage. The intra-assay CV for SAA was cal-
culated from 13 duplicate samples by averaging the CV
(%) for each of the individual duplicates. Intra-assay CV
for Hp was calculated in the same manner, based on
seven duplicates. Inter-assay CV was calculated from
the average CV value from two assays run six months
apart. One assay was the same as used for intra-assay
CV calculations and the other only contained one dupli-
cate sample.
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